Clinical Trials in Tennessee

Showing 10681-10700 of 15,329 trials

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

This phase I trial studies the side effects and best dose of giving bortezomib and romidepsin together in treating patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), indolent B-cell lymphoma, peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma (CTCL). Bortezomib and romidepsin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

LeukemiaLymphoma

Virginia Commonwealth University18 participantsStarted Apr 2010

Chicago, Illinois, United States • Baltimore, Maryland, United States • Chapel Hill, North Carolina, United States +2 more locations

COMPLETEDPhase 229 miles

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

NCT00859937

This phase II trial is studying how well dasatinib works in treating patients with malignant salivary gland tumors that have come back after treatment or have spread to other parts of the body. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Malignant Salivary Gland NeoplasmRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic Carcinoma+1 more

National Cancer Institute (NCI)55 participantsStarted Mar 2009

Beverly Hills, California, United States • Duarte, California, United States • Los Angeles, California, United States +31 more locations

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

Find Trials by Condition in Tennessee

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

A Study in Participants With Type 2 Diabetes Mellitus

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

Fosamprenavir Versus Other Protease Inhibitors

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Cornea Preservation Time Study

A Study for Patients With Type 1 Diabetes

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve

Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17